litlas
Log inCreate account

Manish A. Shah

Active 1993–2025

143
Papers
30,704
Citations
83
h-index
138
i10-index

Citations

Citations per year for Manish A. Shah1993: 10 citations1994: 16 citations1995: 14 citations1996: 12 citations1997: 15 citations1998: 21 citations1999: 27 citations2000: 34 citations2001: 31 citations2002: 44 citations2003: 38 citations2004: 44 citations2005: 79 citations2006: 96 citations2007: 107 citations2008: 117 citations2009: 123 citations2010: 155 citations2011: 166 citations2012: 152 citations2013: 165 citations2014: 174 citations2015: 170 citations2016: 178 citations2017: 246 citations2018: 228 citations2019: 962 citations2020: 1,241 citations2021: 1,249 citations2022: 1,101 citations2023: 868 citations2024: 1,534 citations2025: 768 citations2026: 17 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,987 citing papers, 23.2% of this breakdownChina: 2,414 citing papers, 18.8% of this breakdownUnited Kingdom: 718 citing papers, 5.6% of this breakdownJapan: 633 citing papers, 4.9% of this breakdownItaly: 628 citing papers, 4.9% of this breakdownGermany: 572 citing papers, 4.5% of this breakdownSouth Korea: 416 citing papers, 3.2% of this breakdownFrance: 414 citing papers, 3.2% of this breakdownCanada: 408 citing papers, 3.2% of this breakdownSpain: 294 citing papers, 2.3% of this breakdownNetherlands: 288 citing papers, 2.2% of this breakdownAustralia: 250 citing papers, 2% of this breakdown
0%23.2%Other 22%

Institutions

Fields

  • Medicine60.8%
  • Biochemistry, Genetics and Molecular Biology18.6%
  • Neuroscience12.5%
  • Immunology and Microbiology4.6%
  • Engineering0.6%
  • Computer Science0.4%
  • Other2.5%

Topics

  • Cancer Immunotherapy and Biomarkers6.3%
  • Gastric Cancer Management and Outcomes5.9%
  • Esophageal Cancer Research and Treatment4.5%
  • Genetic Neurodegenerative Diseases3.9%
  • Pancreatic and Hepatic Oncology Research2.7%
  • HER2/EGFR in Cancer Research2.3%
  • Other74.4%

Coauthors

All papers

Open in search
  1. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

    Authors: Jong‐Mu Sun, Lin Shen, Manish A. Shah, Peter C. Enzinger, Antoine Adenis, Toshihiko Doi, Takashi Kojima, Jean‐Philippe Metges, Zhigang Li, Sung‐Bae Kim, Byoung Chul Cho, Wasat Mansoor, Shau-Hsuan Li, Patrapim Sunpaweravong, María Maqueda, Eray Goekkurt, Hiroki Hara, Luís Carlos Moreira Antunes, Christos Fountzilas, Akihito Tsuji, Victor Castro Oliden, Qi Liu, Sukrut Shah, Pooja Bhagia, Ken Kato - The Lancet 2021 cited by 1,580

  2. Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial

    Authors: Kohei Shitara, Florian Lordick, Yung‐Jue Bang, Peter C. Enzinger, David H. Ilson, Manish A. Shah, Eric Van Cutsem, Rui‐Hua Xu, Giuseppe Aprile, Jianming Xu, Joseph Chao, Roberto Pazo-Cid, Yoon‐Koo Kang, Jianning Yang, Diarmuid Moran, Pranob Bhattacharya, Ahsan M. Arozullah, Jung Wook Park, Mok Oh, Jaffer A. Ajani - The Lancet 2023 cited by 711

  3. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

    Authors: Manish A. Shah, Kohei Shitara, Jaffer A. Ajani, Yung‐Jue Bang, Peter C. Enzinger, David H. Ilson, Florian Lordick, Eric Van Cutsem, Javier Gállego, Jing Huang, Lin Shen, Sang Cheul Oh, Patrapim Sunpaweravong, Hwoei Fen Soo Hoo, Hacı Mehmet Türk, Mok Oh, Jung Wook Park, Diarmuid Moran, Pranob Bhattacharya, Ahsan M. Arozullah, Rui‐Hua Xu - Nature Medicine 2023 cited by 551

  4. Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

    Authors: Charles S. Fuchs, Toshihiko Doi, Raymond Woo-Jun Jang, Kei Muro, Taroh Satoh, Manuela Machado, Weijing Sun, Shadia I. Jalal, Manish A. Shah, Jean-Phillipe Metges, Marcelo Garrido, Talia Golan, Mario Mandalà, Zev A. Wainberg, Daniel V.T. Catenacci, Atsushi Ohtsu, Kohei Shitara, Ravit Geva, Jonathan Bleeker, Andrew H. Ko, Geoffrey Y. Ku, Philip Philip, Peter C. Enzinger, Yung‐Jue Bang, Diane Levitan, Jiangdian Wang, Minori Koshiji Rosales, Rita P. Dalal, Harry H. Yoon - JAMA Oncology 2018 cited by 1,812

  5. Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

    Authors: Takashi Kojima, Manish A. Shah, Kei Muro, Éric François, Antoine Adenis, Chih‐Hung Hsu, Toshihiko Doi, Toshikazu Moriwaki, Sung‐Bae Kim, Se‐Hoon Lee, Jaafar Bennouna, Ken Kato, Lin Shen, Peter C. Enzinger, Shukui Qin, Paula Ferreira, Jia Chen, Gustavo Girotto, Christelle de la Fouchardière, Hélène Senellart, Raed Moh’d Taiseer Al-Rajabi, Florian Lordick, Ruixue Wang, Shailaja Suryawanshi, Pooja Bhagia, Soonmo Peter Kang, Jean‐Philippe Metges, on behalf of the KEYNOTE-181 Investigators - Journal of Clinical Oncology 2020 cited by 1,176

  6. Oesophageal cancer

    Authors: Elizabeth Smyth, Jesper Lagergren, Rebecca C. Fitzgerald, Florian Lordick, Manish A. Shah, Pernilla Lagergren, David Cunningham - Nature Reviews Disease Primers 2017 cited by 1,078

  7. Dietary fructose improves intestinal cell survival and nutrient absorption

    Authors: Samuel Taylor, Shakti Ramsamooj, Roger J. Liang, Alyna Katti, Rita Pozovskiy, Neil Vasan, Seo‐Kyoung Hwang, Navid Nahiyaan, Nancy Francoeur, Emma M. Schatoff, Jared L. Johnson, Manish A. Shah, Andrew J. Dannenberg, Robert Sebra, Lukas E. Dow, Lewis C. Cantley, Kyu Y. Rhee, Marcus D. Goncalves - Nature 2021 cited by 274

  8. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline

    Authors: Manish A. Shah, Erin B. Kennedy, Ashley E. Alarcon-Rozas, Thierry Alcindor, Angela N. Bartley, Aubrey Belk Malowany, Nishin A. Bhadkamkar, Dana C. Deighton, Yelena Y. Janjigian, Asha Karippot, Uqba Khan, Daniel A. King, Kelsey Klute, Jill Lacy, James J. Lee, Rutika Mehta, Sarbajit Mukherjee, Arun Nagarajan, Haeseong Park, Anwaar Saeed, Thomas J. Semrad, Kohei Shitara, Elizabeth Smyth, Nataliya V. Uboha, Melani Vincelli, Zev A. Wainberg, Lakshmi Rajdev - Journal of Clinical Oncology 2023 cited by 202

  9. Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study

    Authors: Peter Thuss‐Patience, Manish A. Shah, Atsushi Ohtsu, Eric Van Cutsem, Jaffer A. Ajani, Hugo R. Castro, Wasat Mansoor, Hyun Cheol Chung, G. Bodoky, Kohei Shitara, Gail D. Lewis Phillips, T. van der Horst, Marie-Laurence Harle-Yge, Betsy Althaus, Yoon‐Koo Kang - The Lancet Oncology 2017 cited by 541

  10. Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study

    Authors: Josep Tabernero, Paulo M. Hoff, Lin Shen, Atsushi Ohtsu, Manish A. Shah, Karen Cheng, Chunyan Song, Haiyan Wu, Jennifer Eng‐Wong, Katherine Kim, Yoon‐Koo Kang - The Lancet Oncology 2018 cited by 478

  11. First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

    Authors: Alexander Starodub, Allyson J. Ocean, Manish A. Shah, Michael J. Guarino, Vincent J. Picozzi, Linda T. Vahdat, Sajeve Thomas, Serengulam V. Govindan, Pius Maliakal, William A. Wegener, Steven A. Hamburger, Robert M. Sharkey, David M. Goldenberg - Clinical Cancer Research 2015 cited by 344

  12. Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer

    Authors: Jérémy Goc, Mengze Lv, Nicholas J. Bessman, Anne-Laure Flamar, Sheena Sahota, Hiroaki Suzuki, Fei Teng, Gregory Putzel, Gérard Eberl, David R. Withers, Janelle C. Arthur, Manish A. Shah, Gregory F. Sonnenberg - Cell 2021 cited by 207

  13. Metastatic Pancreatic Cancer: ASCO Guideline Update

    Authors: Davendra Sohal, Erin B. Kennedy, Pelin Cinar, Thierry Conroy, Mehmet Sitki Copur, Christopher H. Crane, Ignacio Garrido‐Laguna, Michelle Lau, Tyler Johnson, Smitha Krishnamurthi, Cassadie Moravek, Eileen M. O’Reilly, Philip A. Philip, Shubham Pant, Manish A. Shah, Vaibhav Sahai, Hope E. Uronis, Neeha Zaidi, Daniel A. Laheru - Journal of Clinical Oncology 2020 cited by 289

  14. Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2

    Authors: Lei Zhou, Coco Chu, Fei Teng, Nicholas J. Bessman, Jérémy Goc, Endi K. Santosa, Gregory Putzel, Hiroki Kabata, Judith R. Kelsen, Robert N. Baldassano, Manish A. Shah, Robbyn Sockolow, Éric Vivier, Gérard Eberl, Kendall A. Smith, Gregory F. Sonnenberg - Nature 2019 cited by 293

  15. Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo, Sara Lonardi, Salah‐Eddin Al‐Batran, Eric Van Cutsem, David H. Ilson, María Alsina, Ian Chau, Jill Lacy, Michel Ducreux, Guillermo Ariel Mendez, Alejandro Molina Alavez, Daisuke Takahari, Wasat Mansoor, Peter C. Enzinger, Vera Gorbounova, Zev A. Wainberg, Susanna Hegewisch‐Becker, David Ferry, Ji Lin, Roberto Carlesi, Mayukh Das, Manish A. Shah, Alexander Luft, Nina Karaseva, Rubén Dario Kowalyszyn, Carlos Alberto Hernández, Tibor Csőszi, Ferdinando De Vita, Per Pfeiffer, Naotoshi Sugimoto, Judit Kocsis, Andràs Csilla, G. Bodoky, Georgina Garnica Jaliffe, Светлана Проценко, Ayman Madi, Elżbieta Wójcik, Baruch Brenner, Gunnar Folprecht, Tomasz Sarosiek, Katriina Peltola, Peter Bono, Hubert Ayala, Giuseppe Aprile, Cardellino Giovanni Gerardo, Fidel David Huitzil Melendez, Alfredo Falcone, Francesco Di Costanzo, Moustapha Tehfe, Laurent Mineur, Pilar Alfonso, Radka Obermannová, Hélène Senellart, Russell Petty, Leslie Samuel, Péter Ács, Maen Hussein, M. Nechaeva, Frans Erdkamp, Elizabeth Won, Johanna C. Bendell, Javier Gállego, Sylvie Lorenzen, Bohuslav Melichar, Miguel Angel Escudero, Denis Pezet, Jean–Marc Phelip, Diego Kaen, James A. Reeves, Federico Longo Muñoz, Srinivasan Madhusudan, Carlo Barone, Luis Fein, Ángel Gómez Villanueva, Mohamed Hebbar, Jana Prausová, L. Visa Turmo, J. Vidal Barrull, Mette Yilmaz, Alex Beny, Hanneke W.M. van Laarhoven, Brian DiCarlo, Taito Esaki, Kazumasa Fujitani, Karen Geboes, Ravit Geva, Shigenori Kadowaki, Stephen Leong, Nozomu Machida, Moses S. Raj, Francisco Javier Ramírez Godinez, Ágnes Ruzsa, Hugo Ford, William Lawler, Nicolas Robert Maisey, Jiřı́ Petera, Einat Shacham‐Shmueli, Isabelle Sinapi and 44 more - The Lancet Oncology 2019 cited by 284

  16. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline

    Authors: Manish A. Shah, Erin B. Kennedy, Daniel V.T. Catenacci, Dana C. Deighton, Karyn A. Goodman, Narinder K. Malhotra, Christopher G. Willett, Brendon M. Stiles, Prateek Sharma, Laura H. Tang, Bas P. L. Wijnhoven, Wayne L. Hofstetter - Journal of Clinical Oncology 2020 cited by 334

  17. Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors

    Authors: Albiruni RA Razak, James M. Cleary, Víctor Moreno, Michael Boyer, Emiliano Calvo Aller, William J. Edenfield, Jeanne Tie, R. Donald Harvey, Annemie Rutten, Manish A. Shah, Anthony J. Olszanski, Dirk Jäger, Nehal J. Lakhani, David P. Ryan, Erik Rasmussen, Gloria Juan, Hansen Wong, Neelesh Soman, Marie-Anne Damiette Smit, Dirk Nagorsen, Kyriakos P. Papadopoulos - Journal for ImmunoTherapy of Cancer 2020 cited by 118

  18. Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma

    Authors: Manish A. Shah, Yung‐Jue Bang, Florian Lordick, María Alsina, Meng Chen, Stephen P. Hack, Jean Marie Bruey, Dustin Smith, Ian McCaffery, David S. Shames, See Phan, David Cunningham - JAMA Oncology 2016 cited by 301

  19. Targeting the Cell Cycle: A New Approach to Cancer Therapy

    Authors: Gary K. Schwartz, Manish A. Shah - Journal of Clinical Oncology 2005 cited by 824

  20. Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus

    Authors: Manish A. Shah, Takashi Kojima, Daniel Hochhauser, Peter C. Enzinger, Judith Raimbourg, Antoine Hollebecque, Florian Lordick, Sung‐Bae Kim, Masahiro Tajika, Heung Tae Kim, A. Craig Lockhart, Hendrik-Tobias Arkenau, Farid El-Hajbi, Mukul Gupta, Per Pfeiffer, Qi Liu, Jared Lunceford, Soonmo Peter Kang, Pooja Bhagia, Ken Kato - JAMA Oncology 2018 cited by 519

  21. Implications of reactive oxygen species on cancer formation and its treatment

    Authors: Manish A. Shah, Harry A. Rogoff - Seminars in Oncology 2021 cited by 131

  22. Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma

    Authors: Kohei Shitara, Manish A. Shah, Florian Lordick, Eric Van Cutsem, David H. Ilson, Samuel J. Klempner, Yoon‐Koo Kang, Sara Lonardi, Yi-Ping Hung, Kensei Yamaguchi, Peter C. Enzinger, Tomoko Nakajima, Maria Matsangou, Ying Cao, Ran Li, Diarmuid Moran, Rupesh Pophale, Mok Oh, Radhika Ranganath, Jaffer A. Ajani, Rui‐Hua Xu - New England Journal of Medicine 2024 cited by 85

  23. Improving outcomes in patients with oesophageal cancer

    Authors: Manish A. Shah, Nasser K. Altorki, Pretish Patel, S. Harrison, Adam J. Bass, Julian A. Abrams - Nature Reviews Clinical Oncology 2023 cited by 84

  24. ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma

    Authors: Samuel J. Klempner, Keun‐Wook Lee, Kohei Shitara, Jean‐Philippe Metges, Sara Lonardi, David H. Ilson, Nicola Fazio, Tae‐Yong Kim, Li‐Yuan Bai, Diarmuid Moran, J. Yang, Ahsan M. Arozullah, Jung Wook Park, Jeffrey J. Raizer, Yung‐Jue Bang, Manish A. Shah - Clinical Cancer Research 2023 cited by 78